Entries by oncotron

Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform

Curve’s innovative mammalian cell drug discovery platform to enable identification and optimisation of novel small molecule drug candidates against MSD targets Potentially game-changing platform enables direct discovery of functionally active molecules against difficult to drug targets expressed in their native intracellular environment Southampton, UK, 16th February 2022: Curve Therapeutics (Curve), a private biotechnology company pioneering […]

Head of Drug Discovery

Curve Therapeutics is seeking to appoint a Head of Drug Discovery to lead its innovative small molecule therapeutic programmes from functional hit to development candidate. Curve is an ambitious, VC-backed drug discovery company that is applying its powerful cell-based functional screening platform to address challenging disease-modifying targets. The company’s vision is to use this platform to develop a pipeline of first-in-class small molecule drugs for the treatment of cancer.

Read more